ABLE Act Webinar Set for Nov. 15

The National Disability Institute manages the website www.ablenrc.org that has good information. I watched all the “webinars” and found them informative. A new one is going to be broadcast Nov. 15, 1:00-2:30 CST  (event number 660 742 928),  and likely will be archived with the rest of the webinars on the ABLE NRC website. In the box below, you will find information on the webinar.

I received an email with this information because I signed up for notifications on the ABLE NRC website. Here is all the information you’ll need:

Thank you for registering for the following webinar. Please join it at least 5 minutes before the scheduled starting time so you won’t miss valuable information. Please note that real time captioning will be provided for this webinar. For other accommodation requests, contact us at [email protected] or 202-296-2040.

Topic: ABLE Funds: Understanding the Investment Side of ABLE
Date and Time:
Tuesday, November 15, 2016 2:00 pm, Eastern Standard Time (New York, GMT-05:00)
Tuesday, November 15, 2016 1:00 pm, Central Standard Time (Chicago, GMT-06:00)
Tuesday, November 15, 2016 12:00 pm, Mountain Standard Time (Denver, GMT-07:00)
Tuesday, November 15, 2016 11:00 am, Pacific Standard Time (San Francisco, GMT-08:00)
Event number: 660 742 928

Registration ID: This event does not require a registration ID

——————————————————-
To join the webinar
——————————————————-
Click here  to join the online event. Or copy and paste the following link to a browser:

https://ndiwebinars.webex.com/ndiwebinars/onstage/g.php?MTID=e4919b39c6ed4423ec83ffc565e9e6365

To view in other time zones or languages, please click the link:

https://ndiwebinars.webex.com/ndiwebinars/onstage/g.php?MTID=e1d6e05f37fe6355955df7c564330d6b0

The sound for this webinar will be broadcast through your computer. Please be sure your speakers are turned on or your headphones are plugged in.

If you do not have sound capabilities on your computer or you prefer to listen to the webinar by phone, you can join the teleconference using the number below:

——————————————————-
To join the audio conference only
——————————————————-

Call-in toll-free number (US/Canada): 1-855-244-8681

Call-in toll number (US/Canada): 1-650-479-3207

Global call-in numbers: https://ndiwebinars.webex.com/ndiwebinars/globalcallin.php?serviceType=EC&ED=490627452&tollFree=1

Toll-free dialing restrictions: https://www.webex.com/pdf/tollfree_restrictions.pdf

Access code: 660 742 928

——————————————————-
For assistance

——————————————————-

You can contact NDI Admin at:

[email protected]

To join the event more quickly, you can set up Event Manager before the event starts. Go to: https://ndiwebinars.webex.com/ndiwebinars/ecsetup.php?frommail=1

The playback of UCF (Universal Communications Format) rich media files requires appropriate players. To view this type of rich media files in the meeting, please check whether you have the players installed on your computer by going to https://ndiwebinars.webex.com/ndiwebinars/onstage/systemdiagnosis.php

https://www.webex.com

IMPORTANT NOTICE: This WebEx service includes a feature that allows audio and any documents and other materials exchanged or viewed during the session to be recorded. By joining this session, you automatically consent to such recordings. If you do not consent to the recording, discuss your concerns with the meeting host prior to the start of the recording or do not join the session. Please note that any such recordings may be subject to discovery in the event of litigation.

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Multiple Sclerosis News Today, or its parent company, BioNews Services, and are intended to spark discussion about issues pertaining to multiple sclerosis.